β-catenin pathways for treatment of AML with high PRL-3 phosphatase

Overview of attention for article published in Journal of Hematology & Oncology, March 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,365 followers.

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase. https://t.co/3RWF7DjBif

16 Nov 2019

Reply Repost Favourite

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.: Related Articles A loss-of-function genetic screening reveals synergistic targeting of… https://t.c

09 Mar 2018

Reply Repost Favourite

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase. https://t.co/AX6ufgufs0

09 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.